Range breakout attempt. Can GSK stock regain momentum?

Traders Union
All News
Financial News
GSK slides 0.6% to GBX1,905 today

Highlights

GSK shares remain under broad selling pressure, trading below key short-, medium-, and long-term moving averages.
Technical indicators show weak momentum with a strong sell signal from MACD, mixed oscillators, and no clear oversold or overbought conditions.
Forecasted trading range is GBX1,856 to GBX1,953, with high probability of further downside if support levels break.

Diverging momentum and oscillators underline resistance caps

On the hourly chart, GSK is trading below the MA-20 at GBX1,919 and the MA-50 at GBX1,928, while also remaining under the long-term MA-200 at GBX1,914. The Ichimoku Kijun is set at GBX1,925 and acts as immediate resistance. Momentum is weak, as the Moving Average Convergence Divergence (MACD) signals Strong Sell and the Average Directional Index (ADX) remains Neutral. Relative Strength Index (RSI) is at 47.41 and is in Sell territory, while both the Stochastic RSI and Commodity Channel Index (CCI) are Neutral, indicating no clear overbought or oversold conditions. Bull/Bear Power (BBP) registers as Overbought, suggesting prevailing buyer dominance during a low-volatility session; however, price action is negative and remains close to the daily low, showing a divergence between momentum and oscillator signals.

Limited rebound potential as downside risk dominates outlook

Looking ahead, GSK is expected to trade within a range of GBX1,856 to GBX1,953 over the next few days, which reflects its typical volatility band relative to current levels. The probability of an upward move is considered very low, while the likelihood of further downside is high, making a reversal attempt unlikely. The baseline scenario sees the price holding within the current corridor, with a potential reversal possible only if resistance at higher levels is surpassed. Continued selling pressure and a break below support could prompt a move toward the lower end of the range.

Anton Kharitonov, expert at Traders Union, notes that GSK remains technically weak with price action below all major moving averages. He sees oscillators split, but price pressure still points lower while momentum is negative. The probability of a sustained upward move looks very low unless resistance is reclaimed. "Unless GSK breaks above key resistance levels, I remain defensive on the stock in this range."

Earlier, analysts noted that GSK’s technical outlook signaled ongoing weakness amid persistent downside momentum despite insider buying and pipeline developments. The current setup reinforces this cautious view, with continued selling pressure and weak momentum suggesting traders should remain watchful for a break below support that could trigger further downside risk.

Source of Data: GSK Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.